Learning, memory, and recovery from various neurological insults occur by a process known as neuroplasticity. Neuroplastic changes occur by a variety of physiological processes that modify central nervous system structure and function. The ability to non-invasively induce neuroplastic change in humans is developing as an exciting new field in neuroscience and may ultimately improve treatment outcomes for those suffering various neurological conditions reliant on neuroplasticity for recovery of function. The induction of neuroplastic changes is influenced by several factors, and do not occur evenly throughout the day, but appear to be under circadian control. This review will discuss the known mechanisms and techniques used to induce neuroplasticity, circadian modulation of neuroplasticity, and will discuss the potential implications of these findings for human neurorehabilitation.
INTRODUCTION
The nervous system reorganizes connections between neurons throughout adult life /82/. This reorganization is termed neuroplasticity and is an important process associated with learning new skills, storing memories, and recovering from certain neurological insults. In the past few years, a number of experimental techniques have been developed to induce neuroplastic change in the human cortex. This topic has generated substantial interest because it is hoped that these techniques may ultimately provide novel opportunities to improve treatment outcomes in the diseased or damaged nervous system which rely on neuroplasticity for recovery of function. Indeed, some early studies have demonstrated that functional improvements are possible. Unfortunately, the magnitude of these clinical improvements has been somewhat disappointing. One reason attributed to the poor functional gains is that changes induced with the neuroplasticity protocols are variable and short-lasting, which limits their application in the clinical sphere. Several studies have sought to identify factors that might contribute to the variability of the induced effects, and factors such as genetics /9,48/, age 767,907, previous cortical activity 7367 and attention 7887 have now been shown to influence the magnitude of the neuroplastic changes induced. Another factor that has recently been shown to be important is the time of day 780,817, indicating that circadian changes in various hormones may play an important role. By better understanding which factors mediate the effectiveness of neuroplasticity induction in humans, it is likely that the potential therapeutic benefit of interventions designed to induce neuroplastic changes in the central nervous system would also be maximized. VOLUME 21, NO. 1,2010
NEUROPLASTICITY
The ability of the nervous system to modify the strength of synaptic connections between cells within ..he central nervous system is believed to play a role in the long-term storage of information. This reorganization of neural circuitry or neuroplasticity has been demonstrated throughout the brain in various animal models, including slice preparations of the rodent hippocampus 747, visual cortex /45/, and sensory cortex 1251, and the human temporal cortex /12/. Neuroplasticity has also been demonstrated in vivo, including the primate 7737 and human auditory cortex 7397, and the human visual 7927 and motor 720,417 cortices. As Mi function is relatively easy to assess non-invasively in humans, this region has been most extensively studied in the field of human neuroplasticity.
Mechanisms involved in neuroplasticity
Neuroplastic change occurs by a variety of mechanisms. Rapid changes result from unmasking pre/existing yet silent synaptic connections 737,597, or a post-synaptic modification of neuron excitability 71017. These changes can be caused by several events, including an increase in excitatory neurotransmitter release or a reduction (or removal) of tonic inhibition 711,407. An important mediator of these effects is the inhibitory neurotransmitter gamma/aminobutyric acid (GABA). Both animal and human studies have clearly demonstrated that a reduction of GABA-mediated inhibition facilitates neuroplastic change in Ml 732,37,1077.
Longer-term changes are due to axonal sprouting and regeneration and also to alteration in the number, size, and shape of synapses 711,407. Longer-lasting changes may also be brought about by modulations in synaptic efficacy. Long-lasting potentiation of synapses was first demonstrated in the rabbit hippocampus by Bliss and Lomo 777. The increase in synaptic efficacy is referred to as longterm potentiation (LTP), and requires highfrequency stimulation of excitatory afferents. A decrease in synaptic efficacy can also be induced with lower frequencies of stimulation, and is referred to as long-term depression (LTD) 7227. Several aspects other than the long-term modification of synaptic efficacy make LTP (and LTD) a candidate mechanism for information storage, and thus provide a cellular basis for learning and memory, as well as for the recovery from neurological insult.
To maximize the value of LTP to store information, it would be desirable if this "storage" could be directed to highly localized cortical regions. Indeed, LTP has been shown to be inputspecific because only the active inputs along a pathway at the time of stimulation are potentiated 727. Other inputs to the same cell that are not active are not potentiated. Therefore, LTP can occur at a specific connection to an individual cell, providing the basis for remarkable specificity.
Another important desirable characteristic is that of associativity. Associative plasticity, also referred to as Hebbian or spike/timing dependent plasticity, occurs when synapses linking two cells are strengthened as a result of the two cells being simultaneously active 7307. If an input consistently contributes to the depolarization of the postsynaptic cell, the strength of that connection will be increased. Conversely, if the timing of the arrival of an input does not regularly contribute to the depolarization of the post-synaptic cell, the strength of that connection will be reduced (for review see 7177). It follows that a weak input to a cell, which normally would not be sufficient to depolarize the post-synaptic cell to threshold, could become potentiated if it is active at the same time as a strong convergent input to the same cell 73,557.
The W-methyl-D-aspartate (NMDA) receptor, which is present at most glutamatergic synapses, has several unique structural and functional characteristics 767 that allow it to play an important role in the induction of activity-dependent LTP. Specifically, the NMDA receptor is a ligand-gated (glutamate) ion channel that is blocked by Mg 2+ in a voltage-dependent manner 7687. This characteristic of the NMDA receptor helps explain the property of the spike-timing-dependent associativity of LTP. A strong depolarizing input is required to expel the Mg 2+ from the NMDA receptor and thus allow the neuron to respond to the weaker input, which releases glutamate at the activated NMDA receptor. Activation of the NMDA receptor allows for the introduction of Ca 2+ ions into the postsynaptic cell, which triggers a cascade of effects that ultimately allows for a greater response to a given input. These effects include an increase the expression of post-synaptic receptors, and an increase in neurotransmitter release from the presynaptic terminal (for review see /57/).
In summary, although many mechanisms contribute to the development of physiological changes that produce plasticity in the central nervous system, the most widely studied is LTP. Many of the characteristics of NMDA-receptor dependent LTP make it an attractive and widely accepted candidate mechanism for the storage of information at the level of the individual synapse.
TECHNIQUES FOR THE INDUCTION OF NEUROPLASTICITY IN HUMANS
The ability to induce neuroplastic change in the human cortex offers neuroscientists the exciting prospect of improving functional outcomes in conditions in which neuroplasticity is important for the recovery of function. The majority of these techniques use repetitive trans-cranial magnetic stimulation (rTMS) to non-invasively stimulate the human cortex at high frequency. Although a variety of rTMS paradigms and approaches can be used to induce excitability changes (plasticity) in the human cortex, the mechanisms responsible for the induced changes are thought to be very similar in most cases. In general, lower frequency stimulation (< IHz) reduces excitability /10/ and higher frequency stimulation (> 5Hz) increases excitability /56/. However, the influence of rTMS protocols on cortical excitability is dependent upon a complex interaction between frequency, intensity, and duration of stimulation. This interaction is highlighted by recently developed protocols, such as theta burst stimulation in which the effects on cortical excitability are determined by the temporal pattern of stimulation applied /34/.
We should acknowledge that using the noninvasive techniques currently available, it is impossible to prove definitively what processes are responsible for neuroplastic changes in humans. However, several pieces of evidence suggest that increases in excitability following rTMS protocols reflect LTP-like mechanisms and decreases in excitability reflect LTD-like mechanisms;
processes, which have been well characterized in animal models and involve synaptic strengthening and weakening respectively. Good evidence indicates that the changes induced by rTMS techniques are due to effects within the cortex. For example, a number of studies have used magnetic stimulation of the descending tracts at a level below the cortex /29,87/ to provide evidence that rTMS effects reside within the cortex. Additionally, direct recording from the spinal epidural space have revealed that rTMS has effects on the later components of the descending volleys evoked in corticospinal neurons by TMS, so called I/waves, which reflect the transsynaptic activation of the cortical pyramidal cells /19/.
The time course of the changes induced by rTMS techniques is compatible with at least the short term phase of LTP/LTD. The induced changes develop in a short period (a few seconds to a few minutes) and last for up to an hour /87,100/. These features are consistent with a rapid change in synaptic efficacy, such as typically seen with LTP/LTD protocols. The induced changes reverse typically within an hour, again a finding consistent with LTP/LTD-like mechanisms.
Many forms of LTP and LTD require the activation of NMDA receptors /7,22,58,66/. Huang and colleagues /33/ demonstrated that the changes induced in Ml by theta burst rTMS are blocked when the NMDA receptor antagonist memantine was administered prior to stimulation. Similarly, the increase in corticomotor excitability seen with a combined low frequency rTMS and peripheral nerve stimulation paradigm known as paired associative stimulation (PAS) is blocked in the presence of dextromethorphan /86/, an NMDA receptor antagonist known to block LTP /52/. These findings provide strong evidence for an important role of NMDA receptors in the corticomotor excitability changes seen with rTMS protocols, and again are consistent with LTP/LTDlike mechanisms being involved.
Further evidence that the induced changes in human subjects are due to LTP/LTD-like processes is provided by a study in which intracortical inhibition was modulated and its effect on plasticity induction examined /105Λ Studies in animal models have demonstrated that the administration of the GABA antagonist bicuculline results in both rapid changes in the cortical representation of body parts within Ml 7377 and an increase in the strength of synaptic connections in Ml /32/. Indeed, in many situations it is necessary to reduce GABAergic inhibition to induce LTP. A study by Ziemann and colleagues /105/ found that a period of hand ischemia, which is known to reduce GABAergic inhibition in the contralateral motor cortex, facilitated the induction of plasticity in Ml when using a low frequency rTMS technique.
Although rTMS protocols are usually applied in a single session more, recently the possibility of using repeated sessions over a number of days or weeks has been examined. This approach has been trialed v/hen using rTMS as a potential therapy in a number of conditions such as chronic pain 7437 and stroke /42/. Although as stated above, rTMS effects usually are thought to be due to short-term changes in synaptic efficacy, it is entirely possible that repeated sessions of stimulation may lead to more permanent changes in synaptic connectivity or even neuronal sprouting and regeneration. Indeed, there is some limited evidence that rTMS may increase brain derived neurotrophic factor (BDNF) levels with chronic stimulation protocols /1047. BDNF is an important modulator of neuronal plasticity, as BDNF knockout mice show impaired LTP induction in the hippocampus /51/. In addition, recent human studies show that humans with a BDNF polymorphism (which prevents the expression of BDNF) exhibit less motor training following a repetitive motor training paradigm /47/ and reduced rTMS neuroplasticity 797. Therefore, although impossible to directly assess in humans, good evidence suggests that various stimulation paradigms induce neuro-plastic changes in the human cortex that outlast the period of stimulation and appear to have many character-istics consistent with LTP/LTD-like changes in synaptic efficacy.
Functional correlates of neuroplasticity
For experimental paradigms that induce neuroplasticity in humans to be useful in improving treatment outcomes for various neurological conditions, it is necessary to demonstrate that the circuits that are reorganized are functionally significant. In the motor cortex, for example, do the rTMS paradigms when applied to Ml alter the operation of circuits involved in motor learning?
Motor learning is associated with usagedependant improvements in motor performance. Performance improvements of a training task are associated with short-term /41/ and long-term changes in cortical excitability /41,707, including the rapid functional reorganization of several cortical areas, including the pre-motor area (PMA) and supplementary motor area (SMA), as well as Ml 7837. Such functional changes include the modification of synaptic efficacy (LTP-and LTDlike mechanisms) and the modulation of intracortical inhibition. These changes have been reported in several species including rodents 7467, non-human primates 7697, and humans 713,70,647.
Although motor learning and neuroplasticity induction paradigms both induce LTP-like changes in Ml, it is conceivable (yet unlikely), that different circuits are activated by the two interventions. Strong evidence that both paradigms activate the same structures in Ml was first demonstrated in rat Ml 775,767. Learning a forelimb skill training task resulted in increased synaptic efficacy of the forelimb area of the trained Ml but not the untrained Ml. Another important finding was that the amount of LTP that could be induced by electrical stimulation in a slice preparation taken from the rats following training was less in the trained Ml than in the untrained Ml, whereas the amount of LTD that could be induced was enhanced in the trained Ml 7757. This finding is consistent with the homeostatic theory of plasticity induction 794,957 and provides strong evidence that similar pathways are being activated in the behavioral learning task and in the experimental induction of LTP/LTD. Similar findings have been reported in humans. For example, Ziemann and colleagues 71067 showed that a motor training task, which enhances motor learning in Ml, prevented a subsequent induction of LTP-like changes in Ml with PAS, whereas induction of LTD-like changes using a similar PAS paradigm were enhanced.
Facilitating motor performance improvement with stimulation paradigms that induce neuroplasticity
Several studies have investigated whether induced changes in cortical excitability using rTMS can modify motor performance, with experiments perfonr.ad on both neurologically normal and neurologically compromised subjects. The studies on neurologically normal subjects have produced mixed results. Following rTMS, some investigators have demonstrated changes in the performance of several motor tasks for both the contralateral 7397 and ipsilateral hands 716,507, whereas several other studies have shown no change 735,787. Even in cases in which changes were noted, the effects on motor performance in neurologically normal subjects following changes in cortical excitability appear to be subtle at best. This finding might indicate that the intact motor system is capable of compensating for any change in cortical excitability to maintain performance 7367.
One of the ultimate goals of research investigating the induction of neuroplasticity is to improve treatment outcomes in patients with a damaged or diseased nervous system. It is promising that functional changes have been reported following neuroplasticity intervention in neurologically compromised patients. For example, in chronic stroke patients, repetitive cortical stimulation combined with motor training leads to greater functional gains than rehabilitative training alone 735,447. As these changes have been induced in chronic stroke patients (i.e. > 3 months after infarct), the improvements are unlikely to be due to a spontaneous recovery of function or rehabilitative training, which can be expected in the acute (< 1 week after infarct) phase following stroke. In patients with Parkinson's disease, 15 minutes of 1 Hz paired/pulse (10 ms inter-stimulus interval) rTMS to the region of cerebellum controlling the target hand improved finger tapping speed in the target hand, but not in the non/target hand or in control subjects 7847.
Despite the promising results of these preliminary clinical studies, a major limitation of current rTMS paradigms is the large inter-subject and inter-session variability in effectiveness of the induced effects 726,67,817. Evidence is now growing that a large number of factors influence a subject's neuroplastic response to rTMS. For example, the history of activity in the cortical region targeted /367 and genetic influences 79,47, 517 may be important. Recently, evidence has also been presented that circadian influences may also affect a subject's response to neuroplasticity induction paradigms. Sale et al. 7817 demonstrated that time of day influenced the effectiveness and reproducibility of PAS-induced neuroplastic change. For experiments performed in the afternoon (~1 pm) compared with the morning (~8 am), neuroplastic change was larger, and within-session reliability was improved. These observations were recently extended in a study specifically designed to investigate factors that might contribute to the time-of-day modulation of neuroplastic change in Ml 7807. Several factors whose levels are known to be different throughout the day were assessed, including circulating cortisol levels, as well as the effectiveness of GABA-mediated inhibition. The time-of-day modulation of neuroplasticity induction in Ml was not due to changes in GABA-mediated inhibition. However, a single oral administration of 24 mg hydrocortisone (which is metabolized to cortisol) inhibited neuroplasticity induction in the evening (when circulating cortisol levels are low). This finding provided evidence that changes in circulating cortisol levels are, at least in part, responsible for the time of day modulation of neuroplasticity induction in Ml. It is clear, however, that elevated circulating cortisol levels are not the only contributor to poor neuroplasticity induction in the morning because no significant correlation was found between endogenous cortisol levels and the effectiveness of neuroplasticity induction 7807. This finding indicates that other factors are also important in influencing an individual's response to PAS, but demonstrate for the first time that the time of day and the manipulation of circulating cortisol levels modulate neuro-plasticity induction in human Ml.
CIRCADIAN RHYTHMS AND NEUROPLASTICITY
The roughly 24-hour daily change in light intensity is a powerful modulator of physiological activity. This daily rhythm is known as a circadian rhythm. In mammals, these rhythms are generated by an endogenous pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus 762,897. Surgical destruction of the SCN results in a dramatic loss of rhythmicity in adrenal cortico-sterone release /62/, and drinking and Jocomotor activity /89/, in rats. When individual SCN cells are isolated, they maintain circadian rhythmicity /99/, indicating that rhythmicity is generated intracellularly. Internal rhythmicity is generated by a gene expression cycle, with two interlocked feedback loops consisting of an interacting positive and negative transcriptional/translational-feedback loop /31,747. The resultant phosphorylation and proteolysis of the expressed "clock" proteins are important in imparting the circadian rhythmicity to the SCN.
Although SCN rhythmicity is internally generated, experiments in which the normal lightdark cycle is deliberately modified have shown that the daily oscillations in physiological function do not occur with a strict 24-hour period. Hence, there must be a mechanism to allow resetting and entrainment of the pacemaker, and the resulting circadian rhythm, to the local environmental time /14/. The most powerful environmental signal for resetting the circadian rhythm is light /15/. Several pathways transmit photic information to the SCN, but the main pathway is the retinohypothalamic tract, which provides a direct projection from the retina tc the SCN/63/.
Neuromodulators responsible for circadian effects on neuroplasticity
As extensive neuronal connections between the SCN, the pituitary, and other brain regions are important in hormonal control, it is hardly surprising that the circulating levels of many compounds, including cortisol, melatonin, and thyroid stimulating hormone, exhibit circadian rhythmicity /14/. Smaller, yet significant circadian changes have also been reported in levels of dopamine, glutamate, GABA, prolactin, growth hormone, and parathyroid hormone 78,147. Several of these compounds act as neuromodulators. A neuromodulator is defined as any compound "that regulates or modifies electrical impulses flowing through neural tissues by enhancing, inhibiting, extending or shortening them" 717.
One of the most widely studied neuromodulators is cortisol. Cortisol secretion occurs throughout the day, with the highest plasma concentration occurring in the early morning in humans. This peak is followed by a reduction during the day, reaching a nadir in the evening. Elevated cortisol levels are known to impair LTP and learning and memory. In anesthetized rats, an injection of a corticosterone metabolite impaired LTP induction in the dentate gyrus 7217. Investigations in humans have shown that both acute and chronic increases in cortisol levels impair learning and memory. A single oral dose of hydrocortisone (25 mg) was shown to impair memory retrieval 7187. Oral hydrocortisone administration has been shown to elevate circulating cortisol levels to a level similar to those seen in psychological or physiological stress 7467. A single dose (24 mg) of oral hydrocortisone that resulted in physiological levels of circulating cortisol has also been shown to impair neuroplasticity induction in human Ml 7807. Chronically elevated cortisol levels, as seen in Gushing's syndrome, are accompanied by significant learning and memory deficits 7287.
Melatonin is the principal hormone secreted from the pineal gland. Melatonin levels are highest during the night and lowest during the day 7987. The administration of melatonin to rats inhibits LTP in hippocampal slice preparations 7857, and also has been shown to impair cognitive processing in humans 7777. Therefore, melatonin is a potential candidate for influencing plasticity induction in human subjects, but as yet no evidence has been provided to support this prediction.
Animal studies have demonstrated circadian variation in various aspects of the induction and consolidation of neuroplasticity, including signal transduction along the cyclic adenosine monophosphate (cAMP) transduction pathway, and mitogen-activated protein kinase (MAPK) phosphorylation 7237. Homeostatic mechanisms probably play a role in maintaining a balance between the differing effects of the various neuromodulators on neuroplasticity. When measured in humans, levels of BDNF and cortisol (which have opposing effects on plasticity) were shown to have the same circadian rhythm 757. Therefore, high levels of BDNF are associated with high cortisol levels. It has been proposed that the two neuromodulators might be physiologically coregulated to help maintain homeostasis of plasticity 71037.
REVIEWS INTHENEUROSCIENCES

Sleep
The hormonal modulation of bodily functions is not simply due to the circadian output of the SCN but rather is a complex interaction between these circadian rhythms, light exposure, gender, age, neuroendocrine feedback mechanisms, and the timing of sleep and wakefulness /14/. The levels of several hormones are modulated primarily by sleep rather than by night-time per se. Some of the hormones most strongly modulated by sleep include growth hormone, prolactin, and thyroid stimulating hormone, and to a lesser extent, cortisol.
One major role attributed to sleep is its role in memory formation and retention. Humans trained to learn a motor sequence learnt much more effectively following a night of sleep compared with an equivalent period of time spent awake /103/. Functional imaging studies have shown that when human subjects are deprived of sleep, the ability to commit new experiences to memory is impaired, due to a reduction in hippocampal activation 7977.
Recently, it has been proposed that sleep-in particular slow wave activity during non/rapid eye movement (NREM) sleep-may also play a role in synaptic homeostasis 7937. According to the theory and recently supported by experiments on rats 7967, periods of wakefulness are associated with net synaptic potentiation, whereas sleep is associated with net synaptic depression. Thus, during the waking period, synapses become progressively more saturated with information. To prevent neuronal saturation, synaptic depression (or downscaling) occurs during sleep to maintain homeostasis 793. Such a finding would appear to contradict reports in human Ml of reduced neuroplasticity induction in the morning compared with the evening 7807. Reconciling the apparent disagreement of these two results is difficult, but may be due to differences in the circadian release of various neuromodulators (including corticosterone/cortisol) between rats and humans.
Clearly, both circadian release of hormones and sleep/wake cycles have profound effects on various physiological functions, including learning and memory. Further support for the importance of the circadian system in modulating neuroplasticity has come from recent studies in which the function of the circadian system has been disrupted. Ruby and colleagues 7797 demonstrated that animals with a dysfunctional (arrhythmic) circadian system had impaired declarative memory. Importantly, this effect was independent of the role of the circadian system in organizing sleep and wakefulness.
POTENTIAL THERAPEUTIC IMPLICATIONS
This review has mainly focused on the induction of neuroplasticity in Ml to facilitate motor recovery. The previous section has discussed the role of the circadian system in modulating neuroplasticity. No study to-date has specifically examined whether the learning of a motor task is influenced by time of day. However there is some evidence that the performance of various motor tasks is dependent on time of day 7617, including force discrimination 7617, muscle strength 71027, and a basic motor flicking task 7247.
The therapeutic potential of neuroplasticity induction paradigms extends far wider than targeting the primary motor cortex in conditions characterized by involvement of this area. For example, similar stimulation paradigms have been used in the treatment of depression 727,717, epilepsy 760,917, tinnitus 753,727, schizophrenia 7547, and hyperalgesia 7497. In all these conditions, pathophysiology is associated with cortical hyperor hypo-excitability in particular brain region(s). As with the studies targeting Ml, short-lasting, clinically marginal improvements tend to be reported. This review has discussed the current body of evidence suggesting that the neural processes associated with neuroplasticity have varying effectiveness throughout the day. Therefore, the implication of the limited available data would suggest that the optimum therapeutic efficacy of rTMS could be achieved by application at a specific time of day. As a potential extension to this notion, if the circadian modulation of plasticity induction is mediated by specific neuromodulator(s), then a pharmacological alteration of the levels of these modulators might provide a further novel therapeutic option.
CONCLUSION
Neuroplastic changes in the cortex are important for learning, memory and recovery from various neurological insults. Evidence suggests that the induction of neuroplasticity by noninvasive brain stimulation techniques may improve rehabilitation outcomes for people suffering from neurological conditions reliant on neuroplasticity for recovery of function. However, the functional gains reported so far have been disappointing. The induction of neuroplasticity is more effective in the evening compared with the morning. This effect is influenced by cortisol levels, and probably by circadian variation in other neuromodulators. This situation raises the possibility that the therapeutic induction of neuroplastic change, and presumably any associated functional benefit, could be optimized by considering the time of day at which the intervention is applied.
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